Small Particle Inhaled Steroids in Refractory Steroid-responsive Asthma.

Trial Profile

Small Particle Inhaled Steroids in Refractory Steroid-responsive Asthma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Ciclesonide (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics
  • Acronyms SPIRA
  • Most Recent Events

    • 25 Jul 2013 Accrual to date is 75% according to United Kingdom Clinical Research Network record.
    • 18 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
    • 05 Jun 2013 Accrual to date is 72% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top